Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
HONG KONG--(BUSINESS WIRE)--Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company…